Advertisement
Screener

Onconetix, Inc. (ONCO) Adjustments to Additional Paid in Capital, Other

1.2 / 5 stars · 8/34 Roast Me

Onconetix, Inc. Adjustments to Additional Paid in Capital, Other

Onconetix, Inc. (ONCO) reported Adjustments to Additional Paid in Capital, Other of $4.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.

Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-03-13

  • Onconetix, Inc. adjustments to additional paid in capital, other for the quarter ending 2024-12-31 was $0.00.
  • Onconetix, Inc. adjustments to additional paid in capital, other for fiscal 2025 was $4.37M, a 2666.68% increase from fiscal 2024.
  • Onconetix, Inc. adjustments to additional paid in capital, other for fiscal 2024 was $158.00K, a 305.13% increase from fiscal 2023.
  • Onconetix, Inc. adjustments to additional paid in capital, other for fiscal 2023 was $39.00K.
Period endAdjustments to Additional Paid in Capital, Other 3 monthAdjustments to Additional Paid in Capital, Other 9 monthAdjustments to Additional Paid in Capital, Other 12 month
2025-12-31$4.37M
10-K · filed 2026-03-13
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02
$158.00K
10-K · filed 2025-06-02
2024-09-30$158.00K
10-Q · filed 2024-12-10
2023-12-31$39.00K
10-K · filed 2024-04-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90